NAVINTA LLC
NAVINTA LLC (United States) holds 35 active US FDA Type II Drug Master Files and 4 inactive, has DMF or CEP filings on record for 34 active ingredients, holds 1 active Type IV (excipient) Drug Master File and is linked to 1 FDA-registered manufacturing site. 10 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “NAVINTA LLC: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/navinta-llc
Overview
NAVINTA LLC is an active pharmaceutical ingredient (API) supplier with 36 active FDA Type II Drug Master Files, covering BENDAMUSTINE HYDROCHLORIDE MONOHYDRATE; BENZTROPINE MESYLATE USP; CISATRACURIUM BESYLATE USP; COLESEVELAM HYDROCHLORIDE; CRIZOTINIB; CYCLOPHOSPHAMIDE USP.
Core services & business areas
Active ingredients with DMF or CEP filings
Substances for which NAVINTA LLC holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
NAVINTA LLC holds 35 active (39 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- RILPIVIRINE HYDROCHLORIDEActive2026-04-28
- CISATRACURIUM BESYLATE USPActive2025-06-18
- GLYCEROL PHENYLBUTYRATEActive2025-04-03
- SODIUM PHENYLBUTYRATE USPActive2025-02-24
- TAFAMIDIS MEGLUMINEActive2024-07-29
- TRIHEPTANOINActive2024-03-26
- CRIZOTINIBActive2024-01-08
- DIAZEPAM USPActive2023-09-27
- COLESEVELAM HYDROCHLORIDEActive2023-07-18
- CYCLOPHOSPHAMIDE USPActive2023-03-31
- MARAVIROCActive2022-03-30
- DS166 DRUG SUBSTANCEActive2022-03-25
- MIGLUSTATActive2021-11-10
- PENICILLAMINE USPActive2018-09-28
- FOSAPREPITANT DIMEGLUMINEActive2018-09-27
- DS108 DRUG SUBSTANCEActive2018-09-27
- BENZTROPINE MESYLATE USPActive2018-02-09
- PHENOXYBENZAMINE HYDROCHLORIDE USPActive2017-12-28
- SODIUM NITROPRUSSIDE USPActive2017-06-02
- REMIFENTANIL HYDROCHLORIDEActive2016-09-27
- ROPIVACAINE HYDROCHLORIDE USPActive2016-09-23
- PHYTONADIONE USP (PROCESS A)Active2016-09-20
- TRIENTINE HYDROCHLORIDE USPActive2016-09-15
- DS121 DRUG SUBTANCEActive2016-09-06
- MELPHALAN HYDROCHLORIDEActive2015-09-29
- SEVELAMER HYDROCHLORIDEActive2014-03-25
- SEVELAMER CARBONATEActive2014-01-02
- BENDAMUSTINE HYDROCHLORIDE MONOHYDRATEActive2013-09-19
- TAUROLIDINEActive2010-12-28
- HYDRALAZINE HYDROCHLORIDE USP (P) GRADEActive2010-10-28
- HYDRALAZINE HYDROCHLORIDE USPActive2006-10-26
- NICARDIPINE HYDROCHLORIDE USPActive2006-09-15
- FOMEPIZOLEActive2006-08-10
- ROPIVACAINEActive2005-12-30
- SODIUM FERRIC GLUCONATE COMPLEXActive2005-07-29
- CYCLOPHOSPHAMIDE USP (STERILE)Inactive2021-09-28
- SODIUM 4-PHENYLBUTYRATEInactive2007-07-18
- DEFEROXAMINE MESYLATE USPInactive2007-02-09
- IRON SUCROSE COMPLEXInactive2005-04-11
Excipient Drug Master Files
NAVINTA LLC holds 1 active (1 total) FDA Type IV Drug Master File. A Type IV DMF covers an excipient, colourant or flavour, not an active ingredient; these are counted separately from the API filings above.
- SALCAPROZATE SODIUMActive2021-10-27
Registered manufacturing sites (1)
Physical sites registered with the US FDA and resolved to NAVINTA LLC, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
10 FDA enforcement records linked to this company.
- 4832019-03-28
Failure to submit scientific article
- 4832017-08-18
Failure to maintain records
- 4832017-08-18
Incomplete periodic safety report
- 4832017-08-18
Late submission of 15-day report
- 4832017-08-18
Late submission of an ICSR
- warning_letter2016-09-26
FDA Warning Letter (drug product)
- 4832016-05-16
Timely submission
- 4832016-05-16
Interval
- 4832016-05-16
Failure to develop written procedures
- recall — Class II2015-04-15
Lack of Assurance of Sterility. A recent FDA inspection reported GMP violations potentially impacting product quality and sterility.
Is this NAVINTA LLC?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.